Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 Gag major homology region (MHR) is a highly conserved 20-amino acid sequence located within the C-terminal domain (CTD) of the capsid (CA) protein (UniProt: P04591). This motif is nearly universal among orthoretroviruses, suggesting a fundamental role in the viral life cycle and structural integrity (PubMed: 8120549). Biologically, the MHR is essential for the proper assembly of the immature Gag polyprotein lattice and the subsequent formation of the mature, infectious viral core during the budding process (PubMed: 15564416). Mutations within the MHR typically result in severe assembly defects, leading to the production of non-infectious, morphologically aberrant virions or a complete failure in particle release (PubMed: 9223631). Due to its high degree of conservation and critical structural function, the MHR is a significant target for the development of capsid assembly inhibitors (PubMed: 27129250). Therapeutic interventions targeting this region, such as experimental peptides and small molecules, aim to disrupt the protein-protein interactions necessary for viral replication. While clinical capsid inhibitors like Lenacapavir target broader interfaces, the MHR remains a focal point for research into next-generation antiretroviral therapies.
Inhibition of Gag multimerization and viral capsid assembly by disrupting protein-protein interactions within the major homology region, preventing the formation of infectious virions.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV-1 Gag major homology region (MHR).